A carregar...
Overcoming Resistance to FLT3 Inhibitors in the Treatment of FLT3-Mutated AML
Acute myeloid leukaemia (AML) carrying internal tandem duplication (ITD) of Fms-Like Tyrosine kinase 3 (FLT3) gene is associated with high risk of relapse and poor clinical outcome upon treatment with conventional chemotherapy. FLT3 inhibitors have been approved for the treatment of this AML subtype...
Na minha lista:
| Publicado no: | Int J Mol Sci |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7073218/ https://ncbi.nlm.nih.gov/pubmed/32102366 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijms21041537 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|